Women's Health
- Vitamin D: A metabolic bone disease perspective
When checking levels, clinicians should keep in mind that vitamin D levels fluctuate by season and time of day, and that different laboratories may use different assays that yield different results.
- Bone turnover markers to monitor oral bisphosphonate therapy
Rapid changes in levels of bone turnover markers can be useful in monitoring the effectiveness of therapy and improving adherence to therapy.
- Making best use of bone turnover markers to monitor oral bisphosphonate therapy
Clinical applications of bone turnover markers can include determining when to start or end a bisphosphonate “holiday” and measuring treatment response.
- Reducing the risk of breast cancer
Breast cancer remains the most common malignancy in US women. Reducing this burden involves identification of high-risk individuals and personalized risk management.
- What are the considerations in patient selection and timing of risk-reducing mastectomy?
The option of risk-reducing mastectomy is for those at highest risk, and multidisciplinary conversations setting patient expectations are critical for optimal patient outcomes.
- Mondor disease of the breast
A 43-year-old woman had 2 weeks of pain and skin tightness over the right breast. Ultrasonography revealed a noncompressible, dilated, subcutaneous vein without flow.
- Women’s health update: A literature review impacting primary care
The authors review cardiovascular disease, bone health, breast cancer risk, cervical cancer prevention, postpartum depression, pelvic pain, and emergency contraception.
- A brownish erythematous patch in the nipple-areola complex
Biopsy revealed neoplastic cells throughout the epidermis and granular layer, with abundant pale cytoplasm, intraglandular extension, and chronic inflammation in the papillary dermis.
- Managing stage 1 hypertension: Consider the risks, stop the progression
Guidelines on managing patients with stage 1 hypertension and a low 10-year risk of atherosclerotic cardiovascular disease.
- Psychogenic nonepileptic seizure: An empathetic, practical approach
Barriers to care include clinician misperceptions, lack of acceptance of the diagnosis, poor patient engagement with treatment, and lack of access to care.